IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
IQVIA (NYSE:IQV) has been ranked No. 1 in the Health Care: Pharmacy and Other Services category on the 2025 Fortune® World's Most Admired Companies™ list for the fourth consecutive year. This marks the company's eighth consecutive appearance on the prestigious list.
The company secured top positions in four key attributes: innovation, global competitiveness, people management, and use of corporate assets. The recognition was based on Fortune® and Korn Ferry's comprehensive survey of over 3,300 executives, analyzing 650 companies across nine different attributes, including global business effectiveness, talent management, investment value, and environmental responsibility.
IQVIA Chairman and CEO Ari Bousbib attributed this achievement to the company's employees' dedication to advancing their mission of accelerating innovation for a healthier world. The Fortune® World's Most Admired Companies™ list, established in 1997, serves as a definitive assessment of corporate reputations, evaluating companies based on their industry standing and broader business practices.
IQVIA (NYSE:IQV) è stata classificata al primo posto nella categoria Assistenza Sanitaria: Farmacia e Altri Servizi sulla lista delle 2025 Fortune® World's Most Admired Companies™ per il quarto anno consecutivo. Questo segna l'ottava apparizione consecutiva dell'azienda su questa prestigiosa lista.
L'azienda ha ottenuto posizioni di vertice in quattro attributi chiave: innovazione, competitività globale, gestione delle persone e utilizzo delle risorse aziendali. Il riconoscimento si basa su un'ampia indagine condotta da Fortune® e Korn Ferry su oltre 3.300 dirigenti, analizzando 650 aziende in nove diversi attributi, tra cui efficacia commerciale globale, gestione dei talenti, valore degli investimenti e responsabilità ambientale.
Il presidente e CEO di IQVIA, Ari Bousbib, ha attribuito questo successo alla dedizione dei dipendenti dell'azienda nel portare avanti la loro missione di accelerare l'innovazione per un mondo più sano. La lista delle Fortune® World's Most Admired Companies™, istituita nel 1997, funge da valutazione definitiva delle reputazioni aziendali, valutando le aziende in base alla loro posizione nel settore e alle pratiche commerciali più ampie.
IQVIA (NYSE:IQV) ha sido clasificada en el primer lugar en la categoría Atención Sanitaria: Farmacia y Otros Servicios en la lista de 2025 Fortune® World's Most Admired Companies™ por cuarto año consecutivo. Esto marca la octava aparición consecutiva de la empresa en esta prestigiosa lista.
La empresa ocupó las posiciones más altas en cuatro atributos clave: innovación, competitividad global, gestión de personas y uso de activos corporativos. El reconocimiento se basó en una encuesta exhaustiva de Fortune® y Korn Ferry entre más de 3,300 ejecutivos, analizando 650 empresas en nueve atributos diferentes, incluyendo efectividad comercial global, gestión del talento, valor de inversión y responsabilidad ambiental.
El presidente y CEO de IQVIA, Ari Bousbib, atribuyó este logro a la dedicación de los empleados de la empresa para avanzar en su misión de acelerar la innovación para un mundo más saludable. La lista de Fortune® World's Most Admired Companies™, establecida en 1997, sirve como una evaluación definitiva de las reputaciones corporativas, evaluando las empresas según su posición en la industria y sus prácticas comerciales más amplias.
IQVIA (NYSE:IQV)는 2025 Fortune® World's Most Admired Companies™ 목록에서 보건 의료: 약국 및 기타 서비스 부문 1위로 선정되었습니다. 이는 4년 연속으로 이루어진 일입니다. 이로써 회사는 이 prestigiosa lista에 8번째로 연속 등장하게 되었습니다.
회사는 네 가지 주요 속성에서 최고 자리를 확보했습니다: 혁신, 글로벌 경쟁력, 인사 관리, 기업 자산 활용. 이 인정은 Fortune®과 Korn Ferry가 3,300명 이상의 임원을 대상으로 수행한 종합 설문조사를 기반으로 하며, 650개 회사를 아홉 가지 속성, 즉 글로벌 비즈니스 효율성, 인재 관리, 투자 가치 및 환경적 책임을 포함하여 분석하였습니다.
IQVIA의 회장 겸 CEO인 아리 부스빕은 이 성과를 회사 직원들이 건강한 세상을 위한 혁신 가속화라는 미션에 헌신한 덕분으로 돌렸습니다. 1997년에 설립된 Fortune® World's Most Admired Companies™ 목록은 기업의 명성을 평가하는 확정적인 기준으로 작용하며, 산업 내 위상과 더 넓은 비즈니스 관행을 기반으로 평가합니다.
IQVIA (NYSE:IQV) a été classée numéro un dans la catégorie Santé : Pharmacie et autres services sur la liste des 2025 Fortune® World's Most Admired Companies™ pour la quatrième année consécutive. Cela marque la huitième apparition consécutive de l'entreprise sur cette liste prestigieuse.
L'entreprise a obtenu des positions de tête dans quatre attributs clés : innovation, compétitivité mondiale, gestion des personnes et utilisation des ressources d'entreprise. La reconnaissance était basée sur une enquête complète de Fortune® et Korn Ferry, réalisée auprès de plus de 3 300 cadres, analysant 650 entreprises selon neuf attributs différents, y compris l'efficacité commerciale mondiale, la gestion des talents, la valeur d'investissement et la responsabilité environnementale.
Ari Bousbib, président et PDG d'IQVIA, a attribué cette réussite à l'engagement des employés de l'entreprise à faire avancer leur mission d'accélérer l'innovation pour un monde plus sain. La liste des Fortune® World's Most Admired Companies™, établie en 1997, sert d'évaluation définitive des réputations d'entreprise, évaluant les entreprises en fonction de leur position dans l'industrie et de leurs pratiques commerciales plus larges.
IQVIA (NYSE:IQV) wurde zum vierten Jahr in Folge auf Platz eins in der Kategorie Gesundheitswesen: Apotheken und andere Dienstleistungen der 2025 Fortune® World's Most Admired Companies™-Liste eingestuft. Dies markiert das achte aufeinanderfolgende Erscheinen des Unternehmens auf dieser renommierten Liste.
Das Unternehmen sicherte sich Spitzenpositionen in vier wichtigen Attributen: Innovation, globale Wettbewerbsfähigkeit, Personalmanagement und Nutzung von Unternehmensressourcen. Die Anerkennung basierte auf einer umfassenden Umfrage von Fortune® und Korn Ferry, die über 3.300 Führungskräfte befragte und 650 Unternehmen in neun verschiedenen Attributen analysierte, darunter globale Geschäftseffektivität, Talentmanagement, Investitionswert und Umweltverantwortung.
Der Vorsitzende und CEO von IQVIA, Ari Bousbib, führte diesen Erfolg auf das Engagement der Mitarbeiter des Unternehmens zurück, die ihre Mission vorantreiben, Innovationen für eine gesündere Welt zu beschleunigen. Die Fortune® World's Most Admired Companies™-Liste, die 1997 ins Leben gerufen wurde, dient als definitive Bewertung von Unternehmensreputation und bewertet Unternehmen basierend auf ihrer Branchenstellung und breiteren Geschäftspraktiken.
- None.
- None.
“We are deeply honored to be recognized for the fourth year in a row as number one on the World’s Most Admired Companies list for our category, and to be named to the list for the eighth consecutive year,” said IQVIA Chairman and CEO Ari Bousbib. “This distinction reflects the dedication and impact our employees have in advancing our mission to accelerate innovation for a healthier world. Their commitment and deep expertise drive innovative medical treatments that enhance patient outcomes globally.”
The Fortune® World's Most Admired Companies™ list is the definitive report card on corporate reputations. Since 1997, Fortune® has identified, selected and ranked the World’s Most Admired Companies™, identifying the business practices that make these companies highly regarded among their peers.
Most Admired Company survey methodology
The annual survey, conducted by Fortune® and Korn Ferry, a global organizational consulting firm, is given to top executives, directors and financial analysts, to identify the companies that enjoy the strongest reputations within their industries and across industries.
Fortune® and Korn Ferry analyzed 650 companies and surveyed more than 3,300 executives to measure reputation based on nine different attributes, including each firm’s effectiveness in conducting business globally, its ability to attract, develop, and keep talent, its value as a long-term investment, its innovativeness, its wise use of corporate assets, and its responsibility to the community and environment.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, ensuring that its AI-powered capabilities are grounded in privacy, regulatory compliance, and patient safety. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250204874891/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com)
+1.919.923.6785
Source: IQVIA
FAQ
What ranking did IQVIA (IQV) achieve in the 2025 Fortune World's Most Admired Companies list?
How many years has IQVIA (IQV) appeared on the Fortune World's Most Admired Companies list?
What key attributes earned IQVIA (IQV) first place in its category for 2025?
How many companies and executives were surveyed for the 2025 Fortune World's Most Admired Companies list?